New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril - film coated tablet - 1 mg - active: cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril excipient: hyprolose hypromellose iron oxide yellow macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate titanium dioxide - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

g & a licensing limited - cilazapril - film coated tablet - 1 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

g & a licensing limited - cilazapril - film coated tablet - 2.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

g & a licensing limited - cilazapril - film coated tablet - 5 anhyd milligrams

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - cilazapril monohydrate - film coated tablet - 0.5 anhyd milligrams

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - cilazapril monohydrate - film coated tablet - 1.0 anhyd milligrams

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - cilazapril monohydrate - film coated tablet - 2.5 anhyd milligrams

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products ltd - cilazapril monohydrate - film coated tablet - 5 anhyd milligrams

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg;   - tablet - 1 mg - active: cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f92084 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg;   - tablet - 2.5 mg - active: cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 85f14364 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.